SCHEMBL7869442

SCHEMBL7869442

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCOC)nc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.43
CA2 P00918 1/20 0.43
P4HTM Q9NXG6 2/20 0.42
ALDH1A1 P00352 4/20 0.42
TSHR P16473 2/20 0.41
CYP2C9 P11712 2/20 0.41
LMNA P02545 1/20 0.41
ALB P02768 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GABRA5 P31644 3/20 0.40
GLA P06280 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862801 0.96 CA2 (0.48) EGFRCA2P4HTMALDH1A1HPGD
SCHEMBL7867912 0.94 EGFR (0.47) EGFRP4HTMALDH1A1HPGDKDM4E
SCHEMBL7867827 0.93 KMT2A (0.42) EGFRCA2P4HTMALDH1A1TSHR
SCHEMBL7862739 0.92 HPGD (0.47) EGFRP4HTMALDH1A1LMNAHPGD
SCHEMBL7870566 0.91 EGFR (0.43) EGFRCA2P4HTMALDH1A1TSHR
SCHEMBL7871570 0.91 EGFR (0.45) EGFRP4HTMHPGDGABRA5KMT2A
SCHEMBL7869460 0.91 EGFR (0.43) EGFRCA2P4HTMALDH1A1HPGD
SCHEMBL9574842 0.91 EGFR (0.43) EGFRCA2P4HTMALDH1A1HPGD
SCHEMBL7862723 0.90 SMN1; SMN2 (0.44) P4HTMLMNAGABRA5KMT2A
SCHEMBL7871556 0.89 CA2 (0.47) EGFRCA2ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed